About

Chemo is a multinational pharmaceutical company with almost four decades of experience and commitment in safeguarding and improving people’s health and well-being. As a comprehensive health sciences group, Chemo operates in all areas of the chemical-pharmaceutical industry and specialises in the research, development, manufacturing, sales and marketing of pharmaceutical active ingredients and medicinal products for human and veterinary use. Chemo’s activities are mainly organised into three synergistic business areas: Industrial (Chemo), Branded Generics (Exeltis) and Biosimilars (mAbxience). The group has offices in more than 40 countries in Europe, America, Asia and Africa and has more than 5,000 professionals, 15 factories, 10 R&D centres and 33 affiliated pharmaceutical companies that provide services to more than 1,150 customers in 96 countries around the world. General counsel Sandra Martin Moran leads the overall legal function which contains 17 in-house international counsels capable of supporting the business globally. Given the highly complex nature and supply chain of the products it produces, along with the highly regulated environment it operates in, Chemo Group requires a large volume of contracts to be completed as efficiently as possible. For this reason, it has a dedicated team of commercial, patent litigation and corporate lawyers based in Madrid, London and Lugano that has been described as ‘unique, solid and seamless’ by one source, and which successfully completes around 3,000 commercials contracts yearly, as well as creating complex IP strategies. Chemo Group is constantly looking for opportunities to expand its business areas. In 2016, the legal team has coordinated, negotiated and closed 13 M&A international transactions ranging from investment agreements (share deals, joint ventures, asset deals and portfolios acquisitions) to divestment agreements.